Posts in FDA Approval

New FDA Approvals: The Year of NMOSD

New FDA Approvals: The Year of NMOSD

Time to dive back into a clinical post! Plus, this one has the added bonus of also being a new drug approval post - times THREE. *mic drop* Come take a look into the world of neuroimmunology, and see what pearls you can take away for your own pharmacy practice.

Clinical, FDA Approval, Pharmacy School, Practice, ResidencyStephanie KujawskiJune 1, 2021new drug approvals by FDA, new drug updates, NMOSD MOG, neuromyelitis optica, immunosuppressants for neurological disorders, NMO versus MS, IVIG uses

New FDA Approval: Fetroja

New FDA Approval: Fetroja

Because one can never have too many antibiotics at hand when facing armies of wily bacteria, tl;dr is here to give you the low down on the newest sneaky weapon at hand. Even though this latest cephalosporin makes it increasingly difficult to think in terms of the classic generations, come check out cefiderocol and why it’s extra special in the ID world.

Clinical, FDA Approval, Practice, Pharmacy School, ResidencyStephanie KujawskiSeptember 3, 2020cefiderocol, Fetroja, new cephalosporin antibiotic, medications for resistant bacteria, complicated UTI treatment, carbapenemases resistance treatment, siderophore cephalosporin

New FDA Approval: Zemdri

New FDA Approval: Zemdri

Check it out: a new antibiotic has hit the market! But if and when will you use it?

Clinical, FDA Approval, Pharmacy School, Practice, ResidencyStephanie KujawskiOctober 8, 2018new drug approval, FDA approval, new antibiotics, aminoglycoside, plazomicin, zemdri, ESBL, MDR bacteria, urinary tract infection

New FDA Approval: Epidiolex

New FDA Approval: Epidiolex

Drug

Epidiolex (cannabidiol extract from cannabis)

FDA Approval, Clinical, Pharmacy School, Practice, ProfessionalBrandon DysonAugust 24, 2018fda approval, epidiolex, marijuana legalization, epidiolex cost, epidiolex controlled substance, epidiolex schedule, dravet syndrome treatment, lennox-gastaut treatment, epilepsy treatment

New FDA Approval: Trogarzo

New FDA Approval: Trogarzo

Drug

Ibalizumab-uiyk

Indication

In combination with other antiretrovirals, Trogarzo is indicated for the treatment of HIV-1 in heavily treatment-experienced adults with multi-drug resistant HIV-1 who are failing their current therapy.

Clinical, FDA Approval, Pharmacy School, Practice, ResidencyBrandon DysonMay 22, 2018fda approval, trogarzo approval, hiv therapy cheat sheet, ibalizumab approval, ibalizumab-uiyk, how does trogarzo work, trogarzo cost, trogarzo package insert, ibalizumab cost, ibalizumab package insert

New FDA Approval: Vabomere

New FDA Approval: Vabomere

Drug

Meropenem-Vaborbactam

Indication

FDA approved indications:

Clinical, FDA Approval, Pharmacy School, Practice, ResidencyBrandon DysonJanuary 5, 2018vabomere, new drug, fda approval, vabomere clinical pearls, meropenem, vaborbactam, meropenem/vaborbactam, meropenem-vaborbactam, vabomere approval, vabomere use

New FDA Approval: Mvasi

New FDA Approval: Mvasi

Drug

Bevacizumab-awwb [Mvasi]

Indication

The treatment of specific cancers:

FDA Approval, Clinical, Pharmacy School, PracticeSamuel OhNovember 2, 2017mvasi, bevacizumab, bevacizumab-awwb, mvasi clinical pearls, avastin, avastin cost, mvasi cost, VEGF inhibitor

New FDA Approval: Bevyxxa

New FDA Approval: Bevyxxa

Drug

Betrixaban [Bevyxxa]

Indication

Extended duration Venous thromboembolism (VTE) prophylaxis in hospitalized adult patients at risk for thromboembolic complications.

Clinical, FDA Approval, Pharmacy School, PracticeBrandon DysonAugust 13, 2017betrixaban, bevyxxa, betrixaban cost, bevyxxa cost, direct Xa inhibitor, Xa inhibitor, enoxaparin, lovenox, anticoagulant, extended duration VTE prophylaxis, VTE, PE, DVT

New FDA Approval: Radicava

New FDA Approval: Radicava

Drug

Edaravone [Radicava]

Indication

The treatment of amyotrophic lateral sclerosis.

Clinical, FDA Approval, Pharmacy School, PracticeSamuel OhJune 27, 2017FDA approval, edaravone, radicava, edaravone cost, radicava cost, ALS, amyotrophic lateral sclerosis, antioxidant

New FDA Approval: Ingrezza

New FDA Approval: Ingrezza

Drug

Valbenazine [Ingrezza]

Indication

The treatment of adults with tardive dyskinesia.

Clinical, FDA Approval, Pharmacy School, PracticeBrandon DysonMay 5, 2017valbenazine, ingrezza, ingrezza cost, valbenazine cost, tardive dyskinesia, antipsychotic, first generation antipsychotic, second generation antipsychotic, vmat2 inhibitor, fda approval

New FDA Approval: Parsabiv

New FDA Approval: Parsabiv

Drug

Etelcalcitide [Parsabiv]

Indication

The treatment of secondary hyperparathyroidism in adults on dialysis.

Clinical, FDA Approval, Pharmacy School, PracticeBrandon DysonFebruary 13, 2017hyperparathyroidism, PTH, parathyroid gland, etelcalcitide, Parsabiv, secondary hyperparathyroidism, calcimimetic, phosphate binder, osteoclast, bone resorption, calcium metabolism, sensipar, cinacalcet

New FDA Approval: Vemlidy

New FDA Approval: Vemlidy

Drug

Tenofovir alafenamide [Vemlidy]

Indication

The treatment of adults with chronic hepatitis B virus (HBV) with compensated liver disease

Clinical, FDA Approval, Pharmacy School, PracticeBrandon DysonJanuary 12, 2017Vemlidy, Tenofovir Alafenamide, tenofovir, HBV, Hepatitis B, HIV drugs cheat sheet, Viread